A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis
PHASE1CompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
July 25, 2016
Primary Completion Date
August 30, 2016
Study Completion Date
August 30, 2016
Conditions
Rheumatoid Arthritis
Interventions
DRUG
ASP1707
Oral
DRUG
methotrexate (MTX)
Oral
Trial Locations (1)
MD-2025
Site MD37301, Chisinau
All Listed Sponsors
lead
Astellas Pharma Global Development, Inc.
INDUSTRY
NCT02867306 - A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter